| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3311450 | Hepatology Research | 2006 | 9 Pages |
Abstract
DFPP can be safely performed concomitantly with interferon and ribavirin combination therapy in chronic hepatitis C patients. The combination may contribute to an early virological response. The effect of DFPP on the SVR and its significance remain to be clarified.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Tatsuya Yamashita, Kuniaki Arai, Akito Sakai, Eishiro Mizukoshi, Yoshio Sakai, Takashi Kagaya, Yasunari Nakamoto, Masao Honda, Takashi Wada, Hitoshi Yokoyama, Shuichi Kaneko,